stock.name

Sage Therapeutics Inc

SAGE

Market Cap$1.2B
Close$

Compare Sage Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Sage Therapeutics IncSage Therapeutics Inc-2.20%-68%19-
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$24.23

Current Fair Value

27.3% upside

Undervalued by 27.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.20 Billion
Enterprise Value$447.15 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-9.05
Beta0.67
Outstanding Shares60,106,687
Avg 30 Day Volume890,293

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-2.22
PEG2.85
Price to Sales19.04
Price to Book Ratio1.46
Enterprise Value to Revenue5.17
Enterprise Value to EBIT-0.82
Enterprise Value to Net Income-1
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Sage Therapeutics Inc

CEO: Jeffrey Jonas